NJ sues drug company Janssen, alleging it deceived the public about opioids

November 13, 2018

New Jersey Attorney General Gurbir S. Grewal, shown in Trenton earlier this year.

By Staff

The State of New Jersey announced Tuesday that it has filed a lawsuit against Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc., alleging the company deceived the public about the dangers of two of its opioid products, including their potential for abuse and dependency.

The state alleges that Janssen’s marketing campaign for its products Nucynta and Nucynta ER minimized the risk of opioids, promoted the products as less addictive than other opioids, and targeted the elderly and other “opioid naïve” patients to expand the company’s market.

Continue reading on Philly.com


Update hourly